CNBC January 15, 2020
Key Points
– Moderna is using the “software of life” to help develop treatments for diseases, including one that can be a $5 billion opportunity, CEO Stephane Bancel told CNBC.
– “We have a phase two study going on where we are designing every product for every patient” to personalize cancer treatments, he said in a “Mad Money” interview.
– Amazon Web Services is playing a key role in the clinical trial studies of multiple drugs the biotech firm is looking to produce.
Moderna Therapeutics is working with Amazon‘s cloud service to deliver a new class of medicines that apply messenger RNA, which is the “software of life,” CEO Stephane Bancel said Wednesday.
The biotech company is undergoing clinical trials...
Today's Sponsors
Today's Sponsor